Coinhibitory Molecules in Autoimmune Diseases
Coinhibitory molecules such as CTLA-4, PD-1 and BTLA negatively regulate immune responses. Multiple studies indicate that the deficiency or mutation of coinhibitory molecules leads to the development of autoimmune diseases in mice and humans, indicating that the negative signals from coinhibitory mo...
Saved in:
Main Authors: | Norihiko Watanabe, Hiroshi Nakajima |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2012/269756 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glycoconjugates and Related Molecules in Human Vascular Endothelial Cells
by: Norihiko Sasaki, et al.
Published: (2013-01-01) -
Schistosome-Derived Molecules as Modulating Actors of the Immune System and Promising Candidates to Treat Autoimmune and Inflammatory Diseases
by: Luis Janssen, et al.
Published: (2016-01-01) -
Inflammatory Mediators in Autoimmunity and Systemic Autoimmune Diseases
by: Britt Nakken, et al.
Published: (2015-01-01) -
Coexistence of accompanying autoimmune diseases in adolescents with autoimmune thyroiditis
by: V.I. Pankiv
Published: (2024-11-01) -
Systemic Autoimmune Diseases
by: Guixiu Shi, et al.
Published: (2013-01-01)